Harnessing EGFR Inhibitors to Outwit Malignancies
The Epidermal Growth Factor Receptor (EGFR) is a protein found on the surface of many cells and is involved in regulating processes like cell division and survival. However, mutations or overactivity of this receptor can lead to uncontrolled tumor growth. EGFR inhibitors are precision medicines designed to interrupt this faulty signaling. These treatments, including tyrosine kinase inhibitors...
0 Comments 0 Shares